DK59785A - Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf - Google Patents

Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf Download PDF

Info

Publication number
DK59785A
DK59785A DK59785A DK59785A DK59785A DK 59785 A DK59785 A DK 59785A DK 59785 A DK59785 A DK 59785A DK 59785 A DK59785 A DK 59785A DK 59785 A DK59785 A DK 59785A
Authority
DK
Denmark
Prior art keywords
ahf
fibrinogen
essential
procedure
preparation
Prior art date
Application number
DK59785A
Other languages
English (en)
Other versions
DK59785D0 (da
Inventor
Joseph D Fisher
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24314041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK59785(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of DK59785D0 publication Critical patent/DK59785D0/da
Publication of DK59785A publication Critical patent/DK59785A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
DK59785A 1984-02-09 1985-02-08 Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf DK59785A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/578,724 US4486410A (en) 1984-02-09 1984-02-09 Heat defibrinogenation of AHF preparation

Publications (2)

Publication Number Publication Date
DK59785D0 DK59785D0 (da) 1985-02-08
DK59785A true DK59785A (da) 1985-08-10

Family

ID=24314041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK59785A DK59785A (da) 1984-02-09 1985-02-08 Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf

Country Status (6)

Country Link
US (1) US4486410A (da)
EP (1) EP0151482B1 (da)
JP (1) JPS60184019A (da)
AT (1) ATE62693T1 (da)
DE (1) DE3582504D1 (da)
DK (1) DK59785A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650858A (en) * 1983-03-21 1987-03-17 Nordisk Gentofte A/S Concentrate of the antihemophilic factor VIII and a process for producing it
JPS6171064A (ja) * 1984-09-13 1986-04-11 日本赤十字社 血液成分の分離用器具
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
AU2251288A (en) * 1987-05-15 1988-12-06 Alan I. Rubinstein Sequential improved method for treatment of human blood- clotting factor products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating

Also Published As

Publication number Publication date
DE3582504D1 (de) 1991-05-23
US4486410A (en) 1984-12-04
JPS60184019A (ja) 1985-09-19
EP0151482A3 (en) 1987-10-07
ATE62693T1 (de) 1991-05-15
EP0151482B1 (en) 1991-04-17
DK59785D0 (da) 1985-02-08
EP0151482A2 (en) 1985-08-14

Similar Documents

Publication Publication Date Title
ATE73332T1 (de) Neuartige verwendung von taurolin.
DK1007061T3 (da) Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater
ATE57836T1 (de) Nichtdenaturierte virusfreie biologisch aktive proteinderivate.
DE10075010I2 (de) Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung.
DK0547932T3 (da) Fremgangsmåde til fremstilling af et koncentrat af aktiveret faktor VII med høj renhed
DK0652966T3 (da) Fremgangsmåde til forøgelse af ekspression af virale proteiner
DE69229272T2 (de) Topischer fibrinogenkomplex
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DE3382837T2 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
DE68909124D1 (de) Verwendung von Polyimides als Trennmembranen.
LV10053A (lv) Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DK562189A (da) Fremgangsmaade til isolering af biologisk aktive forbindelser
DK398185D0 (da) Pasteuriseret, hoejrenset faktor viii-praeparat og fremgangsmaade til fremstilling deraf
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
FI865081A0 (fi) Nya (2-imidazolin-2-yl) -fusionerade heteropyridinfoereningar, mellanprodukter anvaendbara vid deras framstaellning och deras anvaendning som herbicider.
DK59785D0 (da) Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf
DK406184D0 (da) Fremgangsmaade til pasteurisering af humanplasma
DK495786A (da) Fremgangsmaade til fremstilling af halogen-magnesium-alanat og alanatets anvendelse
EP0158317A3 (en) Biologic and method of preparing same
Beck et al. Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor)
DK0436712T3 (da) Lim til sammenføjning af humant eller animalsk væv
Cockburn et al. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/vWF
Clark et al. Strategy for purification of coagulation factor concentrates

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment